BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Figueiredo J, Melo S, Carneiro P, Moreira AM, Fernandes MS, Ribeiro AS, Guilford P, Paredes J, Seruca R. Clinical spectrum and pleiotropic nature of CDH1 germline mutations. J Med Genet. 2019;56:199-208. [PMID: 30661051 DOI: 10.1136/jmedgenet-2018-105807] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Fan L, Ma L, Zhu G, Yao S, Li X, Yu X, Pan Y, Wang L. A Genome-wide association study of premolar agenesis in a chinese population. Oral Dis 2023;29:1102-14. [PMID: 34878701 DOI: 10.1111/odi.14095] [Reference Citation Analysis]
2 Ribeiro E, Araújo D, Pereira M, Lopes B, Sousa P, Sousa AC, Coelho A, Rêma A, Alvites R, Faria F, Oliveira C, Porto B, Maurício AC, Amorim I, Vale N. Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines. Biomedicines 2023;11:799. [DOI: 10.3390/biomedicines11030799] [Reference Citation Analysis]
3 Decourtye-Espiard L, Guilford P. Hereditary Diffuse Gastric Cancer. Gastroenterology 2023:S0016-5085(23)00110-5. [PMID: 36740198 DOI: 10.1053/j.gastro.2023.01.038] [Reference Citation Analysis]
4 Porta FM, Blanco MC, Ivanova M, Fusco N, Guerini-rocco E. Pathology and Somatic Alterations in Hereditary Lobular Breast Cancers. Hereditary Gastric and Breast Cancer Syndrome 2023. [DOI: 10.1007/978-3-031-21317-5_11] [Reference Citation Analysis]
5 Pereira J, Melo S, Carneiro P, Fernandes MS, Figueiredo J, Seruca R. Revisiting the Biological and Clinical Impact of CDH1 Missense Variants. Hereditary Gastric and Breast Cancer Syndrome 2023. [DOI: 10.1007/978-3-031-21317-5_6] [Reference Citation Analysis]
6 Ferreira RM, Figueiredo J, Pinto-Ribeiro I, Gullo I, Sgouras DN, Carreto L, Castro P, Santos MA, Carneiro F, Seruca R, Figueiredo C. Activation of Laminin γ2 by Helicobacter pylori Promotes Invasion and Survival of Gastric Cancer Cells With E-Cadherin Defects. J Infect Dis 2022;226:2226-37. [PMID: 36173814 DOI: 10.1093/infdis/jiac397] [Reference Citation Analysis]
7 van der Merwe NC, Ntaita KS, Stofberg H, Combrink HM, Oosthuizen J, Kotze MJ. Implementation of multigene panel testing for breast and ovarian cancer in South Africa: A step towards excellence in oncology for the public sector. Front Oncol 2022;12:938561. [PMID: 36568162 DOI: 10.3389/fonc.2022.938561] [Reference Citation Analysis]
8 Stillman MD, Kusche N, Toledano S, Hilfrank KJ, Yoon C, Gabre JT, Rustgi SD, Hur C, Kastrinos F, Ryeom SW, Yoon SS. Short and long-term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene. J Surg Oncol 2022;126:1413-22. [PMID: 36063148 DOI: 10.1002/jso.27084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bagdasaryan AA, Chubarev VN, Smolyarchuk EA, Drozdov VN, Krasnyuk II, Liu J, Fan R, Tse E, Shikh EV, Sukocheva OA. Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy. Cancers 2022;14:5436. [DOI: 10.3390/cancers14215436] [Reference Citation Analysis]
10 Sibilio A, Curcio A, Toesca A, Rossi EMC, Corso G. Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers. Curr Opin Oncol 2022. [PMID: 36170166 DOI: 10.1097/CCO.0000000000000872] [Reference Citation Analysis]
11 Cosma LS, Schlosser S, Tews HC, Müller M, Kandulski A. Hereditary Diffuse Gastric Cancer: Molecular Genetics, Biological Mechanisms and Current Therapeutic Approaches. Int J Mol Sci 2022;23:7821. [PMID: 35887173 DOI: 10.3390/ijms23147821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Xie D, Chen Y, Wan X, Li J, Pei Q, Luo Y, Liu J, Ye T. The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer. Front Endocrinol 2022;13:916469. [DOI: 10.3389/fendo.2022.916469] [Reference Citation Analysis]
13 Kingsley C, Kourtidis A. Critical roles of adherens junctions in diseases of the oral mucosa. Tissue Barriers 2022;:2084320. [PMID: 35659464 DOI: 10.1080/21688370.2022.2084320] [Reference Citation Analysis]
14 Ruf B, Roggia C, Schroeder C, Mattern S, Fend F, Klag T, Götz M. Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance. J Gastrointest Canc. [DOI: 10.1007/s12029-022-00831-1] [Reference Citation Analysis]
15 Guan B, Wang J, Li X, Lin L, Fang D, Kong W, Tian C, Li J, Yang K, Han G, Wu Y, He Y, Peng Y, Yu Y, He Q, He S, Gong Y, Zhou L, Tang Q. Identification of Germline Mutations in Upper Tract Urothelial Carcinoma With Suspected Lynch Syndrome. Front Oncol 2022;12:774202. [PMID: 35372080 DOI: 10.3389/fonc.2022.774202] [Reference Citation Analysis]
16 Corso G. Pleiotropic cancer manifestations of germline CDH1 mutations: Risks and management. Journal of Surgical Oncology. [DOI: 10.1002/jso.26847] [Reference Citation Analysis]
17 Fang Y, Cao H, Gong X, Chen Y, Zhuang Y, Zhou S, Chen Y, Jiang Y, Ji X, Peng H, Jing X. AFF4 Predicts the Prognosis of Colorectal Cancer Patients and Suppresses Colorectal Cancer Metastasis via Promoting CDH1 Expression. Front Oncol 2022;12:797392. [PMID: 35223479 DOI: 10.3389/fonc.2022.797392] [Reference Citation Analysis]
18 Corso G, Magnoni F, Trovato C, Girardi A, Seruca R, Figueiredo J, Roviello F. Hereditary Gastric Cancer: A New Syndrome. Gastric Cancer: the 25-year R-Evolution 2022. [DOI: 10.1007/978-3-030-73158-8_5] [Reference Citation Analysis]
19 Yadav S, Hu C, Nathanson KL, Weitzel JN, Goldgar DE, Kraft P, Gnanaolivu RD, Na J, Huang H, Boddicker NJ, Larson N, Gao C, Yao S, Weinberg C, Vachon CM, Trentham-Dietz A, Taylor JA, Sandler DR, Patel A, Palmer JR, Olson JE, Neuhausen S, Martinez E, Lindstrom S, Lacey JV, Kurian AW, John EM, Haiman C, Bernstein L, Auer PW, Anton-Culver H, Ambrosone CB, Karam R, Chao E, Yussuf A, Pesaran T, Dolinsky JS, Hart SN, LaDuca H, Polley EC, Domchek SM, Couch FJ. Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast. J Clin Oncol 2021;39:3918-26. [PMID: 34672684 DOI: 10.1200/JCO.21.00640] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
20 Yang Q, Bai X, Li X, Hu W. The Identification of Key Genes and Biological Pathways in Heart Failure by Integrated Bioinformatics Analysis. Comput Math Methods Med 2021;2021:3859338. [PMID: 34868339 DOI: 10.1155/2021/3859338] [Reference Citation Analysis]
21 Garcia-Pelaez J, Barbosa-Matos R, São José C, Sousa S, Gullo I, Hoogerbrugge N, Carneiro F, Oliveira C. Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes. Eur J Med Genet 2022;65:104401. [PMID: 34871783 DOI: 10.1016/j.ejmg.2021.104401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Giannos P, Kechagias KS, Gal A. Identification of Prognostic Gene Biomarkers in Non-Small Cell Lung Cancer Progression by Integrated Bioinformatics Analysis. Biology (Basel) 2021;10:1200. [PMID: 34827193 DOI: 10.3390/biology10111200] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
23 Bernstein-Molho R, Evron E, Yerushalmi R, Paluch-Shimon S. Genetic testing in patients with triple-negative or hereditary breast cancer. Curr Opin Oncol 2021;33:584-90. [PMID: 34474437 DOI: 10.1097/CCO.0000000000000784] [Reference Citation Analysis]
24 Agaoglu NB, Doganay L. Concurrent pathogenic variations in patients with hereditary cancer syndromes. Eur J Med Genet 2021;64:104366. [PMID: 34637943 DOI: 10.1016/j.ejmg.2021.104366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Pan M, Chen GL, Zhen L, Zhang AN, Li DZ. Early prenatal diagnosis of cleft lip and palate in a Chinese woman with a mosaic CDH1 variant. Eur J Obstet Gynecol Reprod Biol 2021;266:45-7. [PMID: 34592648 DOI: 10.1016/j.ejogrb.2021.09.013] [Reference Citation Analysis]
26 Figueiredo J, Mercadillo F, Melo S, Barroso A, Gonçalves M, Díaz-Tasende J, Carneiro P, Robles L, Colina F, Ibarrola C, Perea J, Morais-de-Sá E, Seruca R, Urioste M. Germline CDH1 G212E Missense Variant: Combining Clinical, In Vitro and In Vivo Strategies to Unravel Disease Burden. Cancers (Basel) 2021;13:4359. [PMID: 34503169 DOI: 10.3390/cancers13174359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Katoh H, Ishikawa S. Lifestyles, genetics, and future perspectives on gastric cancer in east Asian populations. J Hum Genet 2021;66:887-99. [PMID: 34267306 DOI: 10.1038/s10038-021-00960-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
28 Furth EE. Grossing of Gastrointestinal Specimens: Best Practices and Current Controversies. Surg Pathol Clin 2020;13:359-70. [PMID: 32773188 DOI: 10.1016/j.path.2020.04.001] [Reference Citation Analysis]
29 Förster A, Brand F, Banan R, Hüneburg R, Weber CAM, Ewert W, Kronenberg J, Previti C, Elyan N, Beyer U, Martens H, Hong B, Bräsen JH, Erbersdobler A, Krauss JK, Stangel M, Samii A, Wolf S, Preller M, Aretz S, Wiese B, Hartmann C, Weber RG. Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin. Acta Neuropathol 2021;142:191-210. [PMID: 33929593 DOI: 10.1007/s00401-021-02307-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Benesch MGK, Bursey SR, O'Connell AC, Ryan MG, Howard CL, Stockley CC, Mathieson A. CDH1 Gene Mutation Hereditary Diffuse Gastric Cancer Outcomes: Analysis of a Large Cohort, Systematic Review of Endoscopic Surveillance, and Secondary Cancer Risk Postulation. Cancers (Basel) 2021;13:2622. [PMID: 34073553 DOI: 10.3390/cancers13112622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
31 Dixon K, Brew T, Farnell D, Godwin TD, Cheung S, Chow C, Ta M, Ho G, Bui M, Douglas JM, Campbell KR, El-Naggar A, Kaurah P, Kalloger SE, Lim HJ, Schaeffer DF, Cochrane D, Guilford P, Huntsman DG. Modelling hereditary diffuse gastric cancer initiation using transgenic mouse-derived gastric organoids and single-cell sequencing. J Pathol 2021;254:254-64. [PMID: 33797756 DOI: 10.1002/path.5675] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Abu-Halima M, Wagner V, Becker LS, Ayesh BM, Abd El-Rahman M, Fischer U, Meese E, Abdul-Khaliq H. Integrated microRNA and mRNA Expression Profiling Identifies Novel Targets and Networks Associated with Ebstein's Anomaly. Cells 2021;10:1066. [PMID: 33946378 DOI: 10.3390/cells10051066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Chen D, Li C, Zhao Y, Zhou J, Wang Q, Xie Y. Bioinformatics analysis for the identification of differentially expressed genes and related signaling pathways in H. pylori-CagA transfected gastric cancer cells. PeerJ 2021;9:e11203. [PMID: 33954041 DOI: 10.7717/peerj.11203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Zheng L, Zhan Y, Lu J, Hu J, Kong D. A prognostic predictive model constituted with gene mutations of APC, BRCA2, CDH1, SMO, and TSC2 in colorectal cancer. Ann Transl Med 2021;9:680. [PMID: 33987378 DOI: 10.21037/atm-21-1010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Corso G, Corso F, Bellerba F, Carneiro P, Seixas S, Cioffi A, La Vecchia C, Magnoni F, Bonanni B, Veronesi P, Gandini S, Figueiredo J. Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review. Cancers (Basel) 2021;13:1269. [PMID: 33809393 DOI: 10.3390/cancers13061269] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
36 Yelskaya Z, Arnold AG, Marcell VJ, Tang LH, Salo-Mullen EE, Strong VE, Stadler ZK, Zhang L. Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) Variant. Eur J Hum Genet 2021;29:1103-9. [PMID: 33619332 DOI: 10.1038/s41431-021-00825-w] [Reference Citation Analysis]
37 Pan H, Ding Y, Jiang Y, Wang X, Rao J, Zhang X, Yu H, Hou Q, Li T. LncRNA LIFR-AS1 promotes proliferation and invasion of gastric cancer cell via miR-29a-3p/COL1A2 axis. Cancer Cell Int 2021;21:7. [PMID: 33407453 DOI: 10.1186/s12935-020-01644-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
38 Gullo I, Oliveira C, van der Post RS, van Dieren JM, Davis JL, Bougen-zhukov N, Guilford P, Carneiro F. Updated perspective and directions on hereditary diffuse gastric cancer. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00011-3] [Reference Citation Analysis]
39 Friedman M, Adar T, Patel D, Lauwers GY, Yoon SS, Mullen JT, Chung DC. Surveillance Endoscopy in the Management of Hereditary Diffuse Gastric Cancer Syndrome. Clin Gastroenterol Hepatol 2021;19:189-91. [PMID: 31678201 DOI: 10.1016/j.cgh.2019.10.033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
40 Marwitz T, Hüneburg R, Spier I, Lau JF, Kristiansen G, Lingohr P, Kalff JC, Aretz S, Nattermann J, Strassburg CP. Hereditary Diffuse Gastric Cancer: A Comparative Cohort Study According to Pathogenic Variant Status. Cancers (Basel) 2020;12:E3726. [PMID: 33322525 DOI: 10.3390/cancers12123726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 Perne C, Steinke-lange V, Aretz S, Spier I. Seltene Tumoren als Leitsymptom hereditärer Tumorsyndrome. best practice onkologie 2020;15:550-565. [DOI: 10.1007/s11654-020-00269-6] [Reference Citation Analysis]
42 Lang GT, Shi JX, Huang L, Cao AY, Zhang CH, Song CG, Zhuang ZG, Hu X, Huang W, Shao ZM. Multiple cancer susceptible genes sequencing in BRCA-negative breast cancer with high hereditary risk. Ann Transl Med 2020;8:1417. [PMID: 33313162 DOI: 10.21037/atm-20-2999] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
43 Iyer P, Moslim M, Farma JM, Denlinger CS. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol 2020;5:52. [PMID: 33073047 DOI: 10.21037/tgh.2020.01.02] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
44 Katona BW, Clark DF, Domchek SM. CDH1 on Multigene Panel Testing: Look Before You Leap. J Natl Cancer Inst 2020;112:330-4. [PMID: 31841163 DOI: 10.1093/jnci/djz229] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
45 Perne C, Steinke-lange V, Aretz S, Spier I. Seltene Tumoren als Leitsymptom hereditärer Tumorsyndrome. Pathologe 2020;41:535-549. [DOI: 10.1007/s00292-020-00806-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
46 Yoshida R. Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer 2020. [PMID: 32862296 DOI: 10.1007/s12282-020-01148-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 24] [Article Influence: 14.3] [Reference Citation Analysis]
47 Hu MN, Hu SH, Zhang XW, Xiong SM, Deng H. Overview on new progress of hereditary diffuse gastric cancer with CDH1 variants. Tumori 2020;106:346-55. [PMID: 32811340 DOI: 10.1177/0300891620949668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
48 Devezas V, Baptista M, Gullo I, Rocha J, Sousa F, Xiaogang W, Preto J, Costa S, Castedo S, Garrido L, Oliveira C, Barbosa E, Carneiro F, Barbosa J. Risk-reducing total gastrectomy in asymptomatic CDH1 carriers. Eur Surg 2020;52:171-178. [DOI: 10.1007/s10353-020-00630-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Caggiari L, Fornasarig M, De Zorzi M, Cannizzaro R, Steffan A, De Re V. Family's History Based on the CDH1 Germline Variant (c.360delG) and a Suspected Hereditary Gastric Cancer Form. Int J Mol Sci 2020;21:E4904. [PMID: 32664545 DOI: 10.3390/ijms21144904] [Reference Citation Analysis]
50 Dorn A, Glaß M, Neu CT, Heydel B, Hüttelmaier S, Gutschner T, Haemmerle M. LINC00261 Is Differentially Expressed in Pancreatic Cancer Subtypes and Regulates a Pro-Epithelial Cell Identity. Cancers (Basel) 2020;12:E1227. [PMID: 32414223 DOI: 10.3390/cancers12051227] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
51 Aronson M, Swallow C, Govindarajan A, Semotiuk K, Cohen Z, Kaurah P, Velsher L, Ambus I, Buckley K, Forster-Gibson C, Meschino WS, Blumenthal A, Kim RH, Brar S. Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancer. Curr Oncol 2020;27:e182-90. [PMID: 32489267 DOI: 10.3747/co.27.5663] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Assumpção P, Araújo T, Khayat A, Ishak G, Santos S, Barra W, Acioli JF, Rossi B, Assumpção P. Hereditary gastric cancer: Three rules to reduce missed diagnoses. World J Gastroenterol 2020; 26(13): 1382-1393 [PMID: 32308342 DOI: 10.3748/wjg.v26.i13.1382] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
53 Perne C, Steinke-lange V, Aretz S, Spier I. Seltene Tumoren als Leitsymptom hereditärer Tumorsyndrome. Onkologe 2020;26:205-218. [DOI: 10.1007/s00761-019-00707-3] [Reference Citation Analysis]
54 Haddad CF. Hereditary breast cancer: review and current approach. Mastology 2020;30. [DOI: 10.29289/25945394202020200042] [Reference Citation Analysis]
55 Xie Z. A systematic review: breast cancer susceptibility genes. E3S Web Conf 2020;218:03039. [DOI: 10.1051/e3sconf/202021803039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Shenoy S. CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management. Cancer Manag Res 2019;11:10477-86. [PMID: 31853199 DOI: 10.2147/CMAR.S208818] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
57 Pritchard CC. New name for breast-cancer syndrome could help to save lives. Nature 2019;571:27-9. [PMID: 31270479 DOI: 10.1038/d41586-019-02015-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
58 Bure IV, Nemtsova MV, Zaletaev DV. Roles of E-cadherin and Noncoding RNAs in the Epithelial-mesenchymal Transition and Progression in Gastric Cancer. Int J Mol Sci 2019;20:E2870. [PMID: 31212809 DOI: 10.3390/ijms20122870] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 12.5] [Reference Citation Analysis]